UNICYCIVE THERAPEUTICS, INC. Share-based Payment Arrangement, Expensed and Capitalized, Amount
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $1.80 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2022-05-12
- UNICYCIVE THERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2022-03-31 was $1.80M.
- UNICYCIVE THERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2021-12-31 was $500.00K.
- UNICYCIVE THERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2021-09-30 was $300.00K.
- UNICYCIVE THERAPEUTICS, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2021 was $2.00M.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 3 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 6 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 9 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month |
|---|---|---|---|---|
| 2022-03-31 | $1.80M 10-Q · filed 2022-05-12 | $2.30M derived: sum of 2 quarters · filed 2022-05-12 | $2.60M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $800.00K derived: sum of 2 quarters · filed 2022-03-31 | $2.00M 10-K · filed 2022-03-31 | |
| 2021-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.50M 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $1.20M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |